Katharina D. Fink

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 31, 2026

Temporal Trends in the Incidence and Prevalence of Multiple Sclerosis in Sweden, 2001-2021.

Temporal Trends in the Incidence and Prevalence of Multiple Sclerosis in Sweden, 2001-2021.

Journal: Neuroepidemiology

Published: March 17, 2026

Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.

Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.

Journal: Neuroepidemiology

Published: March 17, 2026

Family planning and multiple sclerosis - Part 1: Patient perspectives on treatment choices in Sweden.

Family planning and multiple sclerosis - Part 1: Patient perspectives on treatment choices in Sweden.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: February 17, 2026

Family planning and multiple sclerosis - part 2: Does real-world practice align with Swedish treatment guidelines?

Family planning and multiple sclerosis - part 2: Does real-world practice align with Swedish treatment guidelines?

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: February 11, 2026

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.

Journal: Annals of clinical and translational neurology

Published: December 19, 2025

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Journal: Brain : a journal of neurology

Published: May 12, 2025

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Journal: Brain : a journal of neurology

Published: May 12, 2025

Completeness and generalizability of the Swedish MS register.

Completeness and generalizability of the Swedish MS register.

Journal: European journal of epidemiology

Published: January 31, 2025

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Journal: Cell

Published: January 29, 2025

Workplace and social support, treatment satisfaction, and their impact on quality of life in Swedish women with multiple sclerosis: a cross-sectional survey study.

Workplace and social support, treatment satisfaction, and their impact on quality of life in Swedish women with multiple sclerosis: a cross-sectional survey study.

Journal: BMJ open

Published: January 14, 2025

Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis.

Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: October 14, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026